Obesity is a well-known risk factor for cardiovascular diseases including heart failure (HF). However, some literatures suggested better clinical outcomes in obese patients with HF. Since higher body mass index (BMI) levels of HF patients were significantly associated with younger age, the impact of obesity on clinical outcomes in non-elderly HF patients should be elucidated.
O besity is a well-known risk factor for cardiovascular diseases including heart failure (HF). [1] [2] [3] As compared with the normal body mass index population (BMI < 22.5 kg/m 2 ), obesity (BMI > 30 kg/m 2 ) in midlife had approximately 1.6 to 2.6 times greater risk for the development of future HF after adjusting other risk factors. 4) However, the impact of obesity on long-term outcomes in HF patients remains controversial. Some literatures showed an inverse relationship between obesity and mortality in patients with HF, [5] [6] [7] [8] whereas most of these studies focused on elderly HF patients. Since higher BMI levels of HF patients were significantly associated with younger age, 9, 10) the impact of obesity on clinical outcomes in non-elderly HF patients should also be elucidated. Furthermore, clinical characteristics stratified by the presence of obesity in non-elderly HF patients have yet to be revealed. The purpose of this study was to investigate the clinical characteristics and the mid-term outcomes of obesity in patients with HF among Japanese non-elderly population.
Methods

Study design and participants:
This was a single-center, retrospective, observational study. Consecutive 155 nonelderly acute decompensated HF patients (< 60-year-old) who admitted to our institution between 2009 and 2013 were included. Those patients were divided into the two groups according to the BMI: the obesity group (BMI ! 25 kg/m 2 , n = 81) and the non-obesity group (BMI < 25 kg/m 2 , n = 74). We used BMI 25 kg/m 2 as a cut off for obesity according to the recommendation of the Japan Society for the Study of Obesity (JASSO). 11) Clinical followup was performed via patients' medical records. The primary composite outcome of this study was defined as readmission due to HF and all-cause death. The event-free time was calculated from the date of admission until the end point or last follow-up date. This study was approved by the institutional review board. Written informed consent was waived because of the retrospective study design.
Definition of characteristics:
We compared baseline characteristics between the two groups such as cause of HF, echocardiographic parameters, laboratory data, sleepdisordered breathing (SDB) data, and medications. The diagnosis of HF was performed by cardiologists based on the criteria of the Framingham study. 12) The cause of HF was estimated from the medical records. Hypertension was defined as the recent use of antihypertensive drugs, a OBESITY AND HEART FAILURE IN THE NON-ELDERLY Cardiac events were defined as re-admission due to HF and cardiac death. Multivariate Cox regression analysis was applied to the variables that had significant univariate predictive values (P < 0.05). The survival curves of the two groups were drawn using Kaplan-Meier methods, and log-rank test was used to calculate statistical differences. The Cox proportional hazard models were performed to assess the association between the obesity group and long-term outcomes even after controlling age and sex. Hazard ratios (HR) and the 95% confidence interval (CI) were calculated. P < 0.05 was considered statistically significant. All statistical analyses were performed with SPSS software version 18.0.0.
Results
Patient backgrounds of HF in non-elderly:
The comparison of baseline characteristics between the groups is shown in 
Mortality and re-admission due to HF after discharge:
The mean follow-up period was 884 ± 684 days. During the follow-up period, there were 11 cardiac deaths (4 in the obesity group and 7 in the non-obesity group) and 2 non-cardiac deaths. The causes of them consisted of 8 pump failure (2 in the obesity group and 6 in the nonobesity group), 2 ventricular fibrillation (in each group), and 1 nocturnal sudden death (in the obesity group). The causes of non-cardiac deaths were 1 cancer (non-obesity group) and 1 sepsis (obesity group). There were 38 readmissions due to HF. Multivariate Cox regression analyses were applied to the variables that had significant univariate predictive values (P < 0.05) in each group. In the obesity group, hypertension (HR 0.17, 95%CI 0.05-0.57, P < 0.01) and serum creatinine level (HR 1.10, 95%CI 1.03-1.18, P < 0.01) were the independent predictor of cardiac events. In the non-obesity group, hypertension (HR 0.40, 95% CI 0.17-0.95, P = 0.04) and hyperuricemia (HR 0.37, 95%CI 0.16-0.86, P = 0.02) were the predictor of cardiac events (Table II) . The Kaplan-Meier curves of the two groups for the primary composite outcome, all-cause death, and re-admission due to HF are shown in the Figure. The primary composite outcome was significantly less in the obesity group than in the nonobesity group (log-rank, P = 0.047), and re-admission due to HF was also significantly less in the obesity group than in the non-obesity group (log-rank, P = 0.02). The Cox proportional hazard analysis showed that the primary composite outcome was less frequently observed in the obesity group as compared with the non-obesity group after controlling age and sex (HR 0.50, 95% CI 0.26-0.95, P = 0.03). Re-admission due to HF was significantly less in the obesity group than in the non-obesity group (HR 0.44, 95% CI 0.23-0.86, P = 0.02), whereas all-cause death was not significantly different between the groups (P = 0.16) (Table III) .
Discussion
The present study focused on non-elderly population and compared the patients' characteristics and the clinical outcomes between the obesity group and the non-obesity group. We showed that the prevalence of hypertension and the value of AHI were greater in the obesity group, whereas the levels of BNP were significantly lower in the . Log-rank test was used for initial comparison. Cox proportional hazard analysis was used for calculating the unadjusted hazard ratios and 95% confidence intervals. HR indicates hazard ratio; and CI, confidence interval. obesity group. The primary composite outcome was less frequently observed in the obesity group as compared with the non-obesity group, suggesting obesity paradox in this study population. Obesity paradox: There have been some hypotheses explaining the mechanism of the obesity paradox in HF, but Ito, ET AL the clear mechanism has yet to be determined. One explanation was that obese patients might become symptomatic earlier than non-obese patients because baseline levels of natriuretic peptides were generally lower in obese patients than in non-obese patients. 15, 16) The present study also showed that the levels of BNP were significantly lower in the obesity group as compared with the non-obesity group, which supports the above hypothesis. Another explanation was tolerance for optimal medical therapy. Because obese patients usually have hypertension, they might be able to tolerate higher dose of cardio-protective medications such as beta blockers and renin-angiotensin system inhibitors than non-obese patients. Although the types of medications were not different between the two groups in the present study, the prevalence of hypertension was higher in the obesity group than in the nonobesity group. The present study also showed that hypertension was the inverse predictor of cardiac events in each group, which supports the above hypothesis. Furthermore, Khalid U, et al. showed that patients who were overweight or obese before HF development had lower mortality after HF diagnosis compared with normal BMI patients. 17) The additional adipose tissue might provide metabolic reserves for obese patients to survive the future catabolic state caused by the progression of HF. Despite the benefits of weight loss in the prevention of HF, the recommendation of intentional weight loss might not be appropriate for patients with HF. Since there were no largescale studies investigating the effect of weight loss in obese patients with HF, 18) future studies regarding weight management in HF would be needed for pursuing better patients' outcomes.
Clinical characteristics of non-elderly obese patients with HF:
We showed that the prevalence of hypertension and the value of AHI were greater in the obesity group. A follow-up analysis of the Framingham study demonstrated that overweight (BMI 25-29.9 kg/m 2 ) and obesity (BMI ! 30 kg/m 2 ) were related to the increased risk for hypertension and cardiovascular diseases. 19) In addition, the SchlaHF registry demonstrated that BMI was a clinical predictor for the prevalence of SDB and the greater extent of AHI in the patients with chronic HF. 20) In the present study, we showed the consistent results in the non-elderly HF population.
The present study demonstrated that the levels of BNP were significantly lower in the obesity group. BNP levels were generally affected by extra-cardiac factors including renal disease, 21) atrial fibrillation, 22, 23) and obesity. 15, 16, 24) Iwanaga, et al. showed that obese patients had lower BNP levels compared with non-obese patients even with similar hemodynamic severities of HF. 25) Since natriuretic peptides including BNP have some compensatory functions for HF including enhanced diuresis [26] [27] [28] and decreasing vascular resistance, 27, 29) low BNP levels might contribute to the development of HF in obese patients. Furthermore, BNP has been shown to have some metabolic functions including activation of lipolysis, which might lead to weight loss or cachexia in advanced HF patients. 16, 30, 31) Therefore, BNP may be associated with the mechanism of obesity paradox. Further studies are needed to understand the relationship between BNP and obese patients with HF. Study limitations: There are several limitations in the present study. First, as the present study was a singlecenter, retrospective, observational study, there is a risk of selection bias. Second, we divided study patients into only two groups because the total study population was small. In fact, the obese group included 3 extremely obese patients (BMI !40 kg/m 2 ), whereas the non-obese group included 5 lean patients (BMI < 18.5 kg/m 2 ). Since the Ushaped relationship between BMI and outcomes of HF patients was demonstrated, 8, 32) these extremely obese and lean patients might have a significant impact on outcomes in each group. Third, BMI at hospital admission might not reflect the patients' usual body weight because patients with acute decompensated HF tend to have fluid retention at admission. Fourth, as the result of multivariate Cox regression analysis, there were only a few predictors of cardiac events in each group. The cause of this result might be the small sample size of this study. Larger sample size might be needed.
Conclusion
The mid-term outcomes in non-elderly HF patients with obesity were better as compared with non-elderly HF patients without obesity, which supports obesity paradox in this specific population.
